Aclaris Therapeutics Down Over 15%, on Pace for Largest Percent Decrease Since January 2024 -- Data Talk

Dow Jones01-27

Aclaris Therapeutics, Inc. (ACRS) is currently at $3.82, down $0.68 or 15.11%

--Would be lowest close since Jan. 16, 2026, when it closed at $2.62

--On pace for largest percent decrease since Jan. 10, 2024, when it fell 21.48%

--Currently down three of the past four days

--Currently down two consecutive days; down 15.67% over this period

--Worst two day stretch since the two days ending Nov. 15, 2024, when it fell 15.98%

--Up 26.91% month-to-date; on pace for best month since Oct. 2025, when it rose 32.63%

--Up 26.91% year-to-date

--Down 88.42% from its all-time closing high of $32.99 on April 17, 2017

--Up 55.92% from 52 weeks ago (Jan. 27, 2025), when it closed at $2.45

--Down 15.67% from its 52-week closing high of $4.53 on Jan. 22, 2026

--Up 253.7% from its 52-week closing low of $1.08 on April 10, 2025

--Traded as low as $3.77

--Down 16.22% at today's intraday low; largest intraday percent decrease since Nov. 20, 2024, when it fell as much as 20.04%

All data as of 2:26:27 PM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

January 26, 2026 14:29 ET (19:29 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2606223598?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-27 03:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606223598","market":"nz","top_or_hot":-1,"title":"Aclaris Therapeutics Down Over 15%, on Pace for Largest Percent Decrease Since January 2024 -- Data Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  <a href=\"https://laohu8.com/S/ACRS\">Aclaris Therapeutics</a>, Inc. (ACRS) is currently at $3.82, down $0.68 or 15.11% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be lowest close since Jan. 16, 2026, when it closed at $2.62 \n</p>\n<p>\n     --On pace for largest percent decrease since Jan. 10, 2024, when it fell 21.48% \n</p>\n<p>\n     --Currently down three of the past four days \n</p>\n<p>\n     --Currently down two consecutive days; down 15.67% over this period \n</p>\n<p>\n     --Worst two day stretch since the two days ending Nov. 15, 2024, when it fell 15.98% \n</p>\n<p>\n     --Up 26.91% month-to-date; on pace for best month since Oct. 2025, when it rose 32.63% \n</p>\n<p>\n     --Up 26.91% year-to-date \n</p>\n<p>\n     --Down 88.42% from its all-time closing high of $32.99 on April 17, 2017 \n</p>\n<p>\n     --Up 55.92% from 52 weeks ago (Jan. 27, 2025), when it closed at $2.45 \n</p>\n<p>\n     --Down 15.67% from its 52-week closing high of $4.53 on Jan. 22, 2026 \n</p>\n<p>\n     --Up 253.7% from its 52-week closing low of $1.08 on April 10, 2025 \n</p>\n<p>\n     --Traded as low as $3.77 \n</p>\n<p>\n     --Down 16.22% at today's intraday low; largest intraday percent decrease since Nov. 20, 2024, when it fell as much as 20.04% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 2:26:27 PM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 26, 2026 14:29 ET (19:29 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aclaris Therapeutics Down Over 15%, on Pace for Largest Percent Decrease Since January 2024 -- Data Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAclaris Therapeutics Down Over 15%, on Pace for Largest Percent Decrease Since January 2024 -- Data Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-27 03:29</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  <a href=\"https://laohu8.com/S/ACRS\">Aclaris Therapeutics</a>, Inc. (ACRS) is currently at $3.82, down $0.68 or 15.11% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be lowest close since Jan. 16, 2026, when it closed at $2.62 \n</p>\n<p>\n     --On pace for largest percent decrease since Jan. 10, 2024, when it fell 21.48% \n</p>\n<p>\n     --Currently down three of the past four days \n</p>\n<p>\n     --Currently down two consecutive days; down 15.67% over this period \n</p>\n<p>\n     --Worst two day stretch since the two days ending Nov. 15, 2024, when it fell 15.98% \n</p>\n<p>\n     --Up 26.91% month-to-date; on pace for best month since Oct. 2025, when it rose 32.63% \n</p>\n<p>\n     --Up 26.91% year-to-date \n</p>\n<p>\n     --Down 88.42% from its all-time closing high of $32.99 on April 17, 2017 \n</p>\n<p>\n     --Up 55.92% from 52 weeks ago (Jan. 27, 2025), when it closed at $2.45 \n</p>\n<p>\n     --Down 15.67% from its 52-week closing high of $4.53 on Jan. 22, 2026 \n</p>\n<p>\n     --Up 253.7% from its 52-week closing low of $1.08 on April 10, 2025 \n</p>\n<p>\n     --Traded as low as $3.77 \n</p>\n<p>\n     --Down 16.22% at today's intraday low; largest intraday percent decrease since Nov. 20, 2024, when it fell as much as 20.04% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 2:26:27 PM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 26, 2026 14:29 ET (19:29 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ACRS","symbol_name":"Aclaris Therapeutics","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2606223598","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2606223598","pubTimestamp":1769455740,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Aclaris Therapeutics, Inc.  is currently at $3.82, down $0.68 or 15.11%. --Would be lowest close since Jan. 16, 2026, when it closed at $2.62. --On pace for largest percent decrease since Jan. 10, 2024, when it fell 21.48%. --Currently down two consecutive days; down 15.67% over this period. --Up 26.91% month-to-date; on pace for best month since Oct. 2025, when it rose 32.63%. --Down 88.42% from its all-time closing high of $32.99 on April 17, 2017. --Up 55.92% from 52 weeks ago , when it closed at $2.45. --Up 253.7% from its 52-week closing low of $1.08 on April 10, 2025. --Down 16.22% at today's intraday low; largest intraday percent decrease since Nov. 20, 2024, when it fell as much as 20.04%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ACRS":"Aclaris Therapeutics","BK4007":"制药"},"translate_title":"Aclaris Therapeutics股价下跌超过15%，创2024年1月以来最大跌幅——Data Talk","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACRS":1.5},"content_text":"Aclaris Therapeutics, Inc. (ACRS) is currently at $3.82, down $0.68 or 15.11% \n\n\n \n\n\n     --Would be lowest close since Jan. 16, 2026, when it closed at $2.62 \n\n\n     --On pace for largest percent decrease since Jan. 10, 2024, when it fell 21.48% \n\n\n     --Currently down three of the past four days \n\n\n     --Currently down two consecutive days; down 15.67% over this period \n\n\n     --Worst two day stretch since the two days ending Nov. 15, 2024, when it fell 15.98% \n\n\n     --Up 26.91% month-to-date; on pace for best month since Oct. 2025, when it rose 32.63% \n\n\n     --Up 26.91% year-to-date \n\n\n     --Down 88.42% from its all-time closing high of $32.99 on April 17, 2017 \n\n\n     --Up 55.92% from 52 weeks ago (Jan. 27, 2025), when it closed at $2.45 \n\n\n     --Down 15.67% from its 52-week closing high of $4.53 on Jan. 22, 2026 \n\n\n     --Up 253.7% from its 52-week closing low of $1.08 on April 10, 2025 \n\n\n     --Traded as low as $3.77 \n\n\n     --Down 16.22% at today's intraday low; largest intraday percent decrease since Nov. 20, 2024, when it fell as much as 20.04% \n\n\n \n\n\n     All data as of 2:26:27 PM ET \n\n\n \n\n\n     Source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 26, 2026 14:29 ET (19:29 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2606223598","isCrawlerRequest":true}